Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend

Utah Medical Products (Nasdaq: UTMD) appointed Kevin C. Timken, Esq. to its Board of Directors and approved a quarterly cash dividend of $0.31 per share.

Rhea-AI Summary

Utah Medical Products (Nasdaq: UTMD) appointed Kevin C. Timken, Esq. to its Board of Directors and approved a quarterly cash dividend of $0.31 per share.

Mr. Timken served as the company’s outside legal counsel for over 20 years and holds a J.D. from the University of Utah College of Law (1997). The dividend is payable on January 5, 2026 to shareholders of record at the close of business on December 16, 2025, representing a 1.6% increase versus the prior regular quarterly dividend.

Utah Medical Products develops and markets disposable and reusable specialty medical devices focused on women and babies and sells in over 100 countries. More information is available at www.utahmed.com.

Argus Nov 4 session

-0.41% close to close Open Argus

Details

News Market Reaction – UTMD

On Nov 4, the day this news came out, UTMD closed 0.41% below the previous close.

Data tracked by StockTitan Argus for the Nov 4 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SALT LAKE CITY, UT / ACCESS Newswire / November 4, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors has appointed Kevin C. Timken, Esq to its Board of Directors. Mr. Timken, who served as UTMD's outside legal counsel for over twenty years prior to his retirement in 2025, graduated with a J.D. degree from the University of Utah College of Law in 1997. The Board believes his robust understanding of the functional and strategic challenges that the Company faces will be integral for continuing UTMD's future excellent performance.

In addition, the Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on January 5, 2026 to shareholders of record at the close of business on December 16, 2025. This is a 1.6% increase over the prior regular quarterly cash dividend.

Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD's website at www.utahmed.com.

Contact:
Brian Koopman
(801) 566-1200

SOURCE: Utah Medical Products, Inc.

View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Utah Medical Products (UTMD) announce on November 4, 2025?

The company appointed Kevin C. Timken to its board and declared a $0.31 quarterly dividend payable Jan 5, 2026.

When is the UTMD dividend record date and payment date for the $0.31 dividend?

The record date is December 16, 2025 and the payment date is January 5, 2026.

How much did UTMD increase its quarterly dividend by on November 4, 2025?

The board approved a dividend that is a 1.6% increase over the prior regular quarterly dividend.

Who is Kevin C. Timken and what is his experience with UTMD?

Kevin C. Timken is a newly appointed director who served as UTMD’s outside legal counsel for over 20 years and holds a J.D. from the University of Utah (1997).

Will the UTMD November 4, 2025 announcement affect product offerings or markets?

The announcement covers a board appointment and a dividend increase; it does not state changes to product lines or market footprint.

Where can investors find more information about Utah Medical Products (UTMD)?

Investors can visit the company website at www.utahmed.com or contact the investor relations phone number provided by the company.